|
PRMT10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.01559999485946E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.15980000234973E-08 |
| Normal-vs-Stage2 |
5.00129999969623E-07 |
| Normal-vs-Stage3 |
4.0835000048034E-08 |
| Normal-vs-Stage4 |
2.31440000497685E-08 |
| Stage1-vs-Stage2 |
4.939200E-01 |
| Stage1-vs-Stage3 |
4.520000E-01 |
| Stage1-vs-Stage4 |
1.498160E-01 |
| Stage2-vs-Stage3 |
2.510200E-01 |
| Stage2-vs-Stage4 |
1.019790E-01 |
| Stage3-vs-Stage4 |
6.677200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.77469999491132E-08 |
| Normal-vs-AfricanAmerican |
1.26099999997464E-07 |
| Normal-vs-Asian |
1.046440E-02 |
| Caucasian-vs-AfricanAmerican |
7.995600E-01 |
| Caucasian-vs-Asian |
7.381200E-01 |
| AfricanAmerican-vs-Asian |
7.893200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.11049999593516E-08 |
| Normal-vs-Female |
1.43489999882007E-08 |
| Male-vs-Female |
3.512300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.59960000023496E-07 |
| Normal-vs-Extreme_Weight |
2.96230000529363E-08 |
| Normal-vs-Obese |
1.24339999962864E-07 |
| Normal-vs-Extreme_Obese |
2.15279999999929E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.101200E-01 |
| Normal_Weight-vs-Obese |
8.983400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.871200E-01 |
| Extreme_Weight-vs-Obese |
3.305000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.140600E-01 |
| Obese-vs-Extreme_Obese |
7.986400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.60090000040003E-07 |
| Normal-vs-Age(41-60Yrs) |
2.91520000028633E-07 |
| Normal-vs-Age(61-80Yrs) |
4.45750000244161E-08 |
| Normal-vs-Age(81-100Yrs) |
7.0411000363535E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.461200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.163000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.654600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.164040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.581780E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.575800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.06380000031159E-07 |
| Normal-VS-Type2 PRCC |
2.74139999589806E-08 |
| Normal-VS-KIRP CIMP |
3.66679997476638E-09 |
| Normal-VS-Unclassified PRCC |
4.53740000017078E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.388200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.438400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.988400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.782620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.941400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.878000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.38359995366977E-09 |
| Normal-vs-N1 |
1.29439999829728E-08 |
| Normal-vs-N2 |
2.00189997912048E-09 |
| N0-vs-N1 |
9.671000E-01 |
| N0-vs-N2 |
6.481700E-02 |
| N1-vs-N2 |
7.673700E-02 |
|
|
